The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.

FormularyDecisions® is an online platform that provides US healthcare decision-makers (HCDMs) with connections to peer insights, access to evidence-based resources, and bi-directional communication with biopharma companies. AMCP pre-approval information exchange (PIE) webinars, digitized dossiers, comprehensive product summaries, and biosimilars information, along with other tools are available exclusively through FormularyDecisions.

AMCP webinar that gave a perspective and guidance on the early, effective exchange of information relative to the recent release of AMCP Format v4.1.

AMCP webinar that reviewed the rationale for updates included in the AMCP Format Version 4.1.

Partnership Forum: Industry leaders gather together on September 13-14, 2016 to develope recommendations for biopharmaceutical companies and health care decision makers to more easily communicate information on products awaiting FDA approval.

AMCP CEO Blog: Using the best evidence possible to make informed health care decisions is a hallmark of managed care pharmacy.

Press Release: The Academy of Managed Care Pharmacy (AMCP) is pleased to announce the release of Version 4.0 of the AMCP Format for Formulary Submissions, which includes new guidance on emerging health care issues, such as biosimilars and comparative effectiveness research.